Liraglutide CAS:204656-20-2 Mugadziri Mutengesi

Liraglutide rudzi rutsva rwemishonga yehypoglycemic iyo inoshandisa AMP-activated protein kinase nokudaro inowedzera insulin senitivity.Haisi chete ine yakakosha hypoglycemic effect, asiwo ine mabasa ekuderedza uremu, kuderedza kweropa, uye kuvandudzwa kweropa lipid profile.Liraglutide, munhu glucagon-like peptide-1 (GLP-1) receptor agonist, inononoka kubuda mudumbu. , kunowedzera satiety, uye kunoderedza kudya kwevarwere, asi kuderedza chido cheuropi chekudya uye kubvumira muviri Kuwedzera kushandiswa kwesimba kunobatsira mukurasikirwa;inodzivirira chiropa kubudisa glucose yakawandisa uye inokurudzira pancreas kuti ibudise insulin yakawanda kuderedza shuga yeropa;uyezve, liraglutide zvakare ine mabhenefiti emwoyo uye kuchengetedzwa kweitsvo.